{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:09:12Z","timestamp":1761919752416},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T00:00:00Z","timestamp":1381363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0075565","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T16:16:04Z","timestamp":1381508164000},"page":"e75565","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association of Multiple Sclerosis Susceptibility Variants and Early Attack Location in the CNS"],"prefix":"10.1371","volume":"8","author":[{"given":"Ellen M.","family":"Mowry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria R.","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Duquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Villoslada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Malikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Roger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Phillip","family":"Kinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bacchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Waubant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,10,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/jnnp.2008.157305","article-title":"The onset location of multiple sclerosis predicts the location of subsequent relapses","volume":"80","author":"EM Mowry","year":"2009","journal-title":"J? Neurol Neurosurg Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/01.wnl.0000200778.65597.ae","article-title":"IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event","volume":"66","author":"RP Kinkel","year":"2006","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis","volume":"326","author":"RW Beck","year":"1992","journal-title":"N? Engl? J? Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1212\/WNL.0b013e31824f7fdd","article-title":"Randomized controlled trial of atorvastatin in CIS: the STAyCIS study","volume":"78","author":"E Waubant","year":"2012","journal-title":"Neurology"},{"key":"ref5","first-page":"1004","article-title":"Baseline data and rationale for study of riluzole for neuroprotection in early relapsing remitting multiple sclerosis","volume":"16","author":"JF Marcus","year":"2010","journal-title":"Mult Scler"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1002\/ana.410360733","article-title":"Establishment and use of multiple sclerosis registers\u2014EDMUS","volume":"36","author":"C Confavreux","year":"1994","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1177\/1352458508090221","article-title":"Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis","volume":"14","author":"J Toledo","year":"2008","journal-title":"Mult Scler"},{"key":"ref8","volume":"109","unstructured":"Optic Neuritis Study Group (1991) The clinical profile of optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol <volume>109<\/volume>: ;1673\u20131678"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS study group","volume":"343","author":"LD Jacobs","year":"2000","journal-title":"N? Engl? J? Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa073493","article-title":"Risk alleles for multiple sclerosis identified by a genomewide study","volume":"357","year":"2007","journal-title":"N? Engl? J? Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/hmg\/ddp542","article-title":"Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci","volume":"19","year":"2010","journal-title":"Hum Mol Gen"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1073\/pnas.0813310106","article-title":"The role of the CD58 locus in multiple sclerosis","volume":"106","author":"PL DeJager","year":"2009","journal-title":"Proc Natl Acad Sci? U? S? A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/ejhg.2009.41","article-title":"Replication analysis identifies TYK2 as a multiple sclerosis susceptibility gene","volume":"17","author":"M Ban","year":"2009","journal-title":"Eur? J? Hum Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ng.401","article-title":"Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci","volume":"41","author":"PL DeJager","year":"2009","journal-title":"Nat Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/ng.396","article-title":"Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20","volume":"41","year":"2009","journal-title":"Nat Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/hmg\/ddn388","article-title":"Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis","volume":"18","author":"SE Baranzini","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/gene.2009.81","article-title":"Multiple sclerosis susceptibility alleles in African Americans","volume":"11","author":"BA Johnson","year":"2010","journal-title":"Genes Immun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/jhg.2009.96","article-title":"Replication of CD58 and CLEC16 as genome-wide significant risk genes for multiple sclerosis","volume":"54","author":"IA Hoppenbrouwers","year":"2009","journal-title":"J? Hum Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/gene.2008.83","article-title":"The expanding genetic overlap between multiple sclerosis and type I diabetes","volume":"10","year":"2009","journal-title":"Genes Immun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/gene.2010.28","article-title":"IL12A, PHOSPH9\/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci","volume":"11","year":"2010","journal-title":"Genes Immun"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2377-11-155","article-title":"Preliminary study: treatment with intramuscular interferon beta-1a results in increased levels of IL12R\u03b22+ and decreased levels of IL23R+ CD4+ T-lymphocytes in multiple sclerosis","volume":"11","author":"JM Kress-Bennett","year":"2011","journal-title":"BMC Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/jnnp.2007.136440","article-title":"Predictors of the location of multiple sclerosis relapse","volume":"79","author":"S Deen","year":"2008","journal-title":"J? Neurol Neurosurg Psychiatry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.10148","article-title":"Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analysis","volume":"51","author":"RW Beck","year":"2002","journal-title":"Ann Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1073\/pnas.1201453109","article-title":"Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8+ T cells","volume":"109","author":"F Miyagawa","year":"2012","journal-title":"Proc Natl Acad Sci? U? S? A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ng2103","article-title":"Interleukin 7 receptor \u03b1 chain (IL7R) shows allelic and functional association with multiple sclerosis","volume":"39","author":"SG Gregory","year":"2007","journal-title":"Nat Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.4049\/jimmunol.1100626","article-title":"The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation","volume":"187","author":"DM Kofler","year":"2011","journal-title":"J? Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"S Sawcer","year":"2011","journal-title":"Nature"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0075565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T07:03:19Z","timestamp":1540018999000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0075565"}},"subtitle":[],"editor":[{"given":"Sreeram V.","family":"Ramagopalan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,10]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0075565","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,10]]}}}